Development of the first model of a phosphorylated, ATP/Mg2+-containing B-Raf monomer by molecular dynamics simulations: a tool for structure-based design

被引:4
作者
Previtali, Viola [1 ]
Trujillo, Cristina [1 ]
Boisson, Jean-Charles [2 ]
Khartabil, Hassan [3 ,4 ]
Henon, Eric [4 ]
Rozas, Isabel [1 ]
机构
[1] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Chem, 152-160 Pearse St, Dublin 2, Ireland
[2] Univ Reims, EA 3804, CReSTIC, F-51687 Reims, France
[3] Univ Reims, Campus Univ Ardennes, 4 Bd Jean Delautre, F-08000 Charleville Mezieres, France
[4] Univ Reims, CNRS, UMR 7312, ICMR, F-51687 Reims, France
关键词
PROTEIN-KINASES; HYDROGEN-BONDS; BRAF KINASE; ACTIVATION; INHIBITORS; POTENT; PATHWAY; CANCER; MUTATIONS; MECHANISM;
D O I
10.1039/c7cp05038k
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A model of phosphorylated and ATP-containing B-Raf protein kinase is needed as a tool for the structure-based design of new allosteric inhibitors, since no crystal structure of such a system has been resolved. Here, we present the development of such a model as well as a thorough analysis of its structural features. This model was prepared using a systematic molecular dynamics approach considering the presence or absence of both the phosphate group at the Thr599 site and the ATP molecule. Then, different structural features (i.e. DFG motif, Mg2+ binding loop, activation loop, phosphorylation site and alpha C-helix region) were analysed for each trajectory to validate the aimed 2pBRAF_ATP model. Moreover, the structure and activating interactions of this 2pBRAF_ATP model were found to be in agreement with previously reported information. Finally, the model was further validated by means of a molecular docking study with our previously developed lead compound I confirming that this ATP-containing, phosphorylated protein model is suitable for further structure-based design studies.
引用
收藏
页码:31177 / 31185
页数:9
相关论文
共 58 条
[1]   Kinetic and catalytic mechanisms of protein kinases [J].
Adams, JA .
CHEMICAL REVIEWS, 2001, 101 (08) :2271-2290
[2]   Activation loop phosphorylation and catalysis in protein kinases: Is there functional evidence for the autoinhibitor model? [J].
Adams, JA .
BIOCHEMISTRY, 2003, 42 (03) :601-607
[3]   Second nature: Biological functions of the raf-1 "kinase" [J].
Baccarini, M .
FEBS LETTERS, 2005, 579 (15) :3271-3277
[4]   AlgoGen: A tool coupling a linear-scaling quantum method with a genetic algorithm for exploring non-covalent interactions [J].
Barberot, C. ;
Boisson, J. C. ;
Gerard, S. ;
Khartabil, H. ;
Thiriot, E. ;
Monard, G. ;
Henon, E. .
COMPUTATIONAL AND THEORETICAL CHEMISTRY, 2014, 1028 :7-18
[5]   Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase family [J].
Bataille, Carole J. R. ;
Brennan, Meabh B. ;
Byrne, Simon ;
Davies, Stephen G. ;
Durbin, Matthew ;
Fedorov, Oleg ;
Huber, Kilian V. M. ;
Jones, Alan M. ;
Knapp, Stefan ;
Liu, Gu ;
Nadali, Anna ;
Quevedo, Camilo E. ;
Russell, Angela J. ;
Walker, Roderick G. ;
Westwood, Robert ;
Wynne, Graham M. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (09) :2657-2665
[6]   The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data [J].
Berman, Helen ;
Henrick, Kim ;
Nakamura, Haruki ;
Markley, John L. .
NUCLEIC ACIDS RESEARCH, 2007, 35 :D301-D303
[7]   Vemurafenib: the first drug approved for BRAF-mutant cancer [J].
Bollag, Gideon ;
Tsai, James ;
Zhang, Jiazhong ;
Zhang, Chao ;
Ibrahim, Prabha ;
Nolop, Keith ;
Hirth, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (11) :873-886
[8]   The Halogen Bond [J].
Cavallo, Gabriella ;
Metrangolo, Pierangelo ;
Milani, Roberto ;
Pilati, Tullio ;
Priimagi, Arri ;
Resnati, Giuseppe ;
Terraneo, Giancarlo .
CHEMICAL REVIEWS, 2016, 116 (04) :2478-2601
[9]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[10]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954